Shulman L P, Grevengood C, Phillips O P, Gross S J, Mace P C, Elias S
Department of Obstetrics and Gynecology, University of Tennessee, Memphis 38103-2896.
Am J Obstet Gynecol. 1994 Nov;171(5):1373-6. doi: 10.1016/0002-9378(94)90163-5.
Our purpose was to assess the family planning decisions made by women found to be carrying fetuses with chromosome abnormalities or neural tube defects.
We studied the family planning decisions of 132 women carrying fetuses with chromosome abnormalities (n = 91) or neural tube defects (n = 41) with regard to prenatal diagnosis, pregnancy management decision, patient's gravidity, and maternal and gestational age.
Twenty women (17 carrying fetuses with chromosome abnormalities and 3 with fetal neural tube defects) elected permanent sterilization after completion of the affected pregnancy. Only maternal age and fetal chromosome abnormalities were associated with a decision to obtain permanent sterilization.
Most women carrying fetuses with chromosome abnormalities or neural tube defects will not choose permanent sterilization after completion of the pregnancy. Delaying such decisions until resolution of grief and depression is now facilitated by the availability of safe, reliable, and relatively long-term reversible contraceptive agents.
我们的目的是评估被发现怀有染色体异常或神经管缺陷胎儿的女性所做出的计划生育决策。
我们研究了132名怀有染色体异常胎儿（n = 91）或神经管缺陷胎儿（n = 41）的女性在产前诊断、妊娠管理决策、患者孕次以及产妇年龄和孕周方面的计划生育决策。
20名女性（17名怀有染色体异常胎儿，3名怀有胎儿神经管缺陷）在完成受影响的妊娠后选择了永久性绝育。只有产妇年龄和胎儿染色体异常与决定进行永久性绝育有关。
大多数怀有染色体异常或神经管缺陷胎儿的女性在妊娠结束后不会选择永久性绝育。现在，安全、可靠且相对长期可逆的避孕药物的可获得性有助于将此类决策推迟到悲伤和抑郁情绪得到缓解之后。
